Related Experiment Video
Updated: Apr 11, 2026

10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.2K
Harnessing case isolation and ring vaccination to control Ebola
Chad Wells1, Dan Yamin1, Martial L Ndeffo-Mbah1
1Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, Connecticut, United States of America.
Plos Neglected Tropical Diseases
|May 30, 2015
Summary
Ring vaccination, combined with case isolation, could significantly reduce Ebola cases. This strategy is most effective in high-contact settings and can avert up to 8% of infections.
Area of Science:
- Epidemiology
- Mathematical Modeling
- Public Health
Background:
- The West Africa Ebola outbreak necessitated non-pharmaceutical interventions like contact tracing and case isolation.
- Vaccine deployment faced challenges due to experimental nature and limited supplies, precluding mass vaccination campaigns.
Purpose of the Study:
- To evaluate the effectiveness of ring vaccination as a strategy for Ebola elimination.
- To assess the potential impact of combining ring vaccination with case isolation.
Main Methods:
- Development of a pair approximation model for Ebola transmission.
- Parameterization of the model using confirmed incidence data from Liberia and Sierra Leone (June 2014 - January 2015).
Main Results:
- Combined intervention of case isolation and ring vaccination, initiated in fall 2014, could have averted additional cases: up to 126 in Liberia and 560 in Sierra Leone.
- Ring vaccination's marginal benefit is highest in settings with high contact rates, individual clustering, low contact tracing efficacy, or post-exposure vaccine protection.
- Ring vaccination can avert up to an additional 8% of Ebola cases in specific settings.
Conclusions:
- Ring vaccination is a moderately beneficial supplement to existing non-pharmaceutical Ebola control efforts.
- The strategy shows promise for enhancing epidemic control, particularly when combined with robust case isolation.
Related Concept Videos
Cross-reactivity
34.0K
Overview
34.0K
Transmission-based Precautions II: Airborne and Protective Environment
2.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K

